NCT04136275
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +13 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
185 public trials
53 recruiting studies
Lymphoma, T-Cell trial results
Completed
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
NCT05886478
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Hopital Saint Andre Bordeaux, France
- Hopital Saint Louis Paris, France
- CHU Roeun Rouen, France
- Universitätsmedizin Göttingen Göttingen, Germany
NCT01919619
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +24 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04840875
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Beijing Boren Hospital Beijing, Beijing Municipality, China
NCT05260203
- Conditions
- Acute Myeloid Leukemia, Amyloidosis, Anemia, +53 more
- Locations
-
- ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologiche P.O. San Carlo Milan, Milano, Italy
Completed
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
- Locations
-
- British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Completed
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT03061188
- Conditions
- Advanced Solid Neoplasm, Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Completed
Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
NCT00888927
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States
- Stanford Medical Center Stanford, California, United States
- Yale Comprehensive Cancer Center New Haven, Connecticut, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT02341014
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States
NCT00877656
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified